Already part of several collaborations for COVID-19 vaccine candidates, Gaithersburg-based Emergent BioSolutions announced Monday that it will manufacture a potential treatment for the coronavirus called lenzilumab. The drug, which is being developed by California-based Humanigen, Inc., is currently being tested ...
Tagged with: Maryland business COVID-19
Read More »